At a complete loss as to why my post on ihub was r
Post# of 72440
"I think it's fantastic that the elephant p53 story provides another catalyst for discussion and investment. A lot of investors originally bought CTIX because of Kevetrin's potential for activation of p53, often referred to as the "Guardian Angel Gene'" due to it's crucial role in controlling cell mutations. This is a story unlikely to die down and we are on the verge of releasing news from Kevetrin's Phase 1 trial at Dana Farber which will confirm Kevetrin's ability to activate p53 in patients, Totally fantastic and potentially very rewarding for stockholders who ignored the recent b/s attack on our company."